Sequans price target lowered to $20 from $35 at Roth Capital

Roth Capital lowered the firm’s price target on Sequans (SQNS) to $20 from $35 and keeps a Buy rating on the shares. The firm views the company’s Q4 report as solid. The new price target reflects a lower sales licensing outlook, more modest internet of things ramp in the second half of the year, and the removal of eRedCap from the second half of 2027, the analyst tells investors in a research note.